{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:01:38Z","timestamp":1793142098148,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s13181-016-0593-1","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T11:14:13Z","timestamp":1480331653000},"page":"245-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015"],"prefix":"10.1007","volume":"13","author":[{"given":"C. William","family":"Heise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"593_CR1","unstructured":"United States Supreme Court case 2005. Accessible at: http:\/\/www.supremecourt.gov\/opinions\/05pdf\/04-1084.pdf"},{"issue":"1","key":"593_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.103.049882","volume":"306","author":"J Riba","year":"2003","unstructured":"Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther. 2003;306(1):73\u201383.","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"593_CR3","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/0006-2952(77)90007-7","volume":"26","author":"NS Buckholtz","year":"1977","unstructured":"Buckholtz NS, Boggan WO. Monoamine oxidase inhibition in brain and liver produced by \u03b2-carbolines: structure-activity relationships and substrate specificity. Biochem Pharmacol. 1977;26(21):1991\u20136.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"593_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jep.2009.10.030","volume":"127","author":"V Samoylenko","year":"2010","unstructured":"Samoylenko V, Rahman MM, Tekwani BL, Tripathi LM, Wang YH, Khan SI, Khan IA, Miller LS, Joshi VC, Muhammad I. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson\u2019s disease. J Ethnopharmacol. 2010;127(2):357\u201367.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"593_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00443425","volume":"97","author":"PA Pierce","year":"1989","unstructured":"Pierce PA, Peroutka SJ. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology. 1989;97(1):118\u201322.","journal-title":"Psychopharmacology"},{"issue":"3","key":"593_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0091-3057(98)00110-5","volume":"61","author":"RL Smith","year":"1998","unstructured":"Smith RL, Canton H, Barrett RJ, Sanders-Bush E. Agonist properties of N, N-dimethyltryptamine at serotonin 5-HT 2A and 5-HT 2C receptors. Pharmacol Biochem Behav. 1998;61(3):323\u201330.","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"593_CR7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/15563650.2015.1102927","volume":"53","author":"JB Mowry","year":"2015","unstructured":"Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 32nd annual report. Clin Toxicol. 2015;53(10):962\u20131147.","journal-title":"Clin Toxicol"},{"key":"593_CR8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.08.028","volume":"156","author":"JJ Palamar","year":"2015","unstructured":"Palamar JJ, Martins SS, Su MK, Ompad DC. Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug Alcohol Depend. 2015;156:112\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"593_CR9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/jat\/29.8.838","volume":"29","author":"J Sklerov","year":"2005","unstructured":"Sklerov J, Levine B, Moore KA, King T, Fowler D. A fatal intoxication following the ingestion of 5-methoxy-N, N-dimethyltryptamine in an ayahuasca preparation. J Anal Toxicol. 2005;29(8):838\u201341.","journal-title":"J Anal Toxicol"},{"issue":"6","key":"593_CR10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jat\/30.6.406","volume":"30","author":"JC Callaway","year":"2006","unstructured":"Callaway JC, Grob CS, McKenna DJ, Nichols DE, Shulgins A, Tupper KW. A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an ayahuasca preparation. J Anal Toxicol. 2006;30(6):406\u20137.","journal-title":"J Anal Toxicol"},{"key":"593_CR11","doi-asserted-by":"crossref","unstructured":"Alatrash G, Majhail NS, Pile JC. Rhabdomyolysis after ingestion of \u201cfoxy,\u201d a hallucinogenic tryptamine derivative. In: Mayo clinic proceedings 2006 Apr 30 (Vol. 81, No. 4, pp. 550\u2013551). Elsevier.","DOI":"10.4065\/81.4.550"},{"issue":"1","key":"593_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03160901","volume":"1","author":"SC Smolinske","year":"2005","unstructured":"Smolinske SC, Rastogi R, Schenkel S. Foxy methoxy: a new drug of abuse. Journal of medical toxicology. 2005;1(1):23\u20135.","journal-title":"Journal of medical toxicology"},{"issue":"1","key":"593_CR13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","volume":"37","author":"FD Os\u00f3rio","year":"2015","unstructured":"Os\u00f3rio FD, Sanches RF, Macedo LR, dos Santos RG, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JA, Hallak JE. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr. 2015;37(1):13\u201320.","journal-title":"Rev Bras Psiquiatr"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-016-0593-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0593-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0593-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T21:15:18Z","timestamp":1568582118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-016-0593-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s13181-016-0593-1","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}